Journal article
Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism
RC Meex, AJ Hoy, A Morris, RD Brown, JCY Lo, M Burke, RJA Goode, BA Kingwell, MJ Kraakman, MA Febbraio, JW Greve, SS Rensen, MP Molloy, GI Lancaster, CR Bruce, MJ Watt
Cell Metabolism | CELL PRESS | Published : 2015
Abstract
Liver steatosis is associated with the development of insulin resistance and the pathogenesis of type 2 diabetes. We tested the hypothesis that protein signals originating from steatotic hepatocytes communicate with other cells to modulate metabolic phenotypes. We show that the secreted factors from steatotic hepatocytes induce pro-inflammatory signaling and insulin resistance in cultured cells. Next, we identified 168 hepatokines, of which 32 were differentially secreted in steatotic versus non-steatotic hepatocytes. Targeted analysis showed that fetuin B was increased in humans with liver steatosis and patients with type 2 diabetes. Fetuin B impaired insulin action in myotubes and hepatocy..
View full abstractRelated Projects (1)
Grants
Awarded by Diabetes Australia Research Trust
Funding Acknowledgements
We acknowledge the technical assistance of Xiaomin Song, Dana Pascovici, and Thiri Zaw (Australian Proteome Analysis Facility) and Michael de Veer (Monash University). This work was supported by research grants from the National Health and Medical Research Council of Australia (ID 1061278), Diabetes Australia Research Trust (to M.J.W.), and Monash University (to M.J.W.) and fellowships from the National Health and Medical Research Council of Australia (to A.J.H., ID 606766; to M.A.F., ID APP1021168, to B.A.K., ID 1059454; and to M.J.W., IDs 606460 and 1077703).